Recombinant Human TRAIL (TNFSF10)
Catalog No : IGX-RP495
0.00€
0.00€
Shipping cost plus VAT not included , delivery in 7-14 business days
| Product name | Recombinant Human TRAIL (TNFSF10) | ||
|---|---|---|---|
| Catalog No | IGX-RP495 | ||
| Supplier’s Catalog No | IGX-RP495 | ||
| Supplier | ImuGeX | ||
| Source antigen | E. coli | ||
| Reactivity | Human | ||
| Cross reactivity | |||
| Applications | |||
| Molecular weight | 19.5 | ||
| Storage | -70°C | ||
|---|---|---|---|
| Other names | TRAIL, Tumor necrosis factor (Ligand) family member 10, TNFSF10, Apo2 Ligand, TL2<br/>Recombinant Human TNF-Related Apoptosis-Inducing Ligand (TNFSF10) | ||
| Grade | Highly Purified | ||
| Purity | >95% as determined by SDS-PAGE | ||
| Form | Lyophilized from a 0.2 μm filtered solution in PBS with BSA as a carrier protein. | ||
| Reactivity life | 6 months | ||
| Note | For reserch purpose only | ||
| Purity | >95% as determined by SDS-PAGE | ||
| Description | A cytotoxic protein, TRAIL initiates apoptosis in tumor cells by binding the death-signalling receptors; DR4 and DR5. In its active conformation, TRAIL forms homotrimers. TRAIL transcripts have been shown to be constitutively expressed in a variety of human tissues. There are five known TRAIL receptors: two which transduce apoptotic signals, two which function as decoys to block TRAIL-induced apoptosis and osteoptotegrin. | ||
Product Details
© 2020 Imugex All Rights Reserved